On the other hand, the miRNA field would immensely benefit from the development of high throughput technologies and methods for reliable characterization and validation of miRNA targets that are lagging at this time, together with the development of bioinformatic platforms capable of effectively and efficiently integrating the complex combinatorial patterns hidden under the “miRNA code.” Equally thrilling will be the discovery of small molecules that could specifically interact with and modulate the availability of select miRNAs in particular tissues, which would be invaluable to the clinical and therapeutic fields.
